scholarly journals Influenza A virus shedding reduction observed at 12 weeks post‐vaccination when newborn pigs are administered live‐attenuated influenza virus vaccine

2019 ◽  
Vol 13 (3) ◽  
pp. 274-278 ◽  
Author(s):  
Troy J. Kaiser ◽  
Rex A. Smiley ◽  
Brian Fergen ◽  
Marc Eichmeyer ◽  
Marika Genzow
Keyword(s):  
Influenza Virus ◽  
Influenza A Virus ◽  
Virus Vaccine ◽  
Influenza A ◽  
Influenza Virus Vaccine ◽  
Post Vaccination ◽  
Virus Shedding ◽  
Newborn Pigs ◽  
Live Attenuated Influenza Virus

scholarly journals A Lipid/DNA Adjuvant–Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge

2018 ◽  
Vol 218 (6) ◽  
pp. 856-867 ◽  
Author(s):  
Timothy D Carroll ◽  
Sinthujan Jegaskanda ◽  
Shannon R Matzinger ◽  
Linda Fritts ◽  
Michael B McChesney ◽  
...  
Keyword(s):  
Influenza Virus ◽  
Influenza A Virus ◽  
Virus Replication ◽  
Virus Vaccine ◽  
Influenza A ◽  
Rhesus Macaques ◽  
Influenza Virus Vaccine ◽  
Virus Challenge

scholarly journals WHO recommendations for influenza virus vaccine 2002/03

2002 ◽  
Vol 6 (6) ◽  
Author(s):  
J Watson ◽  
M Zambon
Keyword(s):  
Influenza Virus ◽  
General Population ◽  
Influenza A Virus ◽  
Virus Vaccine ◽  
Influenza A ◽  
Influenza Virus Vaccine ◽  
Good Level

The new subtype of the influenza A virus, A(H1N2), is a combination of components present in the strains of the two influenza A subtypes (H1N1 and H3N2) currently contained in the vaccine, and so people who have received the vaccine should have a good level of immunity to the new subtype. People in the general population who have not been vaccinated should also have some immunity due to the circulation of the H1N1 and H3N2 subtypes over the last two decades.

Sign in / Sign up

Export Citation Format

Share Document